(Q34107158)

31 July 2017

1 reference

title

Recent developments in the treatment of hypertriglyceridemia (English)

1 reference

31 July 2017

1 reference

Duriez P

1

1 reference

PubMed ID

11122689

31 July 2017

Fruchart JC

series ordinal

2

1 reference

31 July 2017

1 July 1999

1 reference

Current Atherosclerosis Reports

31 July 2017

1 reference

31 July 2017

1

1 reference

31 July 2017

1

1 reference

31 July 2017

31-37

1 reference

https://scigraph.springernature.com/pub.10.1007/s11883-999-0047-1

31 July 2017

0 references

cites work

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

1 reference

https://api.crossref.org/works/10.1007%2FS11883-999-0047-1

Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-999-0047-1

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-999-0047-1

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-999-0047-1

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-999-0047-1

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

12 December 2020

Secondary preventive potential of lipid-lowering drugs. The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).

1 reference

12 December 2020

Baseline characteristics of patients participating in the Bezafibrate Infarction Prevention (BIP) Study

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia

1 reference

12 December 2020

Lipid-lowering drugs in the management of hyperlipidaemia

1 reference

12 December 2020

Plasma cholesterol concentration and mortality. The Whitehall Study.

1 reference

12 December 2020

Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans

1 reference

12 December 2020

Familial apolipoprotein E deficiency

1 reference

12 December 2020

Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review.

1 reference

12 December 2020

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women.

1 reference

12 December 2020

Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]).

1 reference

12 December 2020

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol

1 reference

12 December 2020

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

12 December 2020

Design features of a five-year Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).

1 reference

12 December 2020

Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Tr

1 reference

12 December 2020

Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study

1 reference

12 December 2020

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

12 December 2020

National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1 reference

12 December 2020

Plasma triglyceride and coronary heart disease

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy

1 reference

12 December 2020

Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans

1 reference

12 December 2020

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group

1 reference

12 December 2020

Plasma triglyceride and low density lipoprotein metabolism

1 reference

12 December 2020

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

12 December 2020

Comparison of statins in hypertriglyceridemia

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Randomized crossover study of gemfibrozil versus lovastatin in familial combined hyperlipidemia: additive effects of combination treatment on lipid regulation.

1 reference

12 December 2020

Cardiovascular Effects of n-3 Fatty Acids

1 reference

12 December 2020

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

12 December 2020

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

12 December 2020

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

12 December 2020

10.1007/S11883-999-0047-1

Identifiers

DOI

1 reference

PubMed ID

11122689

Dimensions Publication ID

31 July 2017

0 references

1 reference

PubMed ID

11122689